Inventor · disambiguated record
W. Blair Geho
Also filed as: GEHO W B · GEHO W BLAIR
33 granted patents·18 pending applications·2,964 citations·filing 1983–2025
98Inventor score
Top patents by PatentIndex Score
51 records- 0199US4501728AMasking of liposomes from RES recognitionTECHNOLOGY UNLIMITED INC·Filed 1983·Granted Feb 26, 1985·2k cites·4 claims
- 0298US4603044AHepatocyte Directed Vesicle delivery systemTECHNOLOGY UNLIMITED INC·Filed 1984·Granted Jul 29, 1986·361 cites·7 claims
- 0397US8257735B2Method of increasing the bioavailability of recombinant human insulin isophane in a patientLAU JOHN R·Filed 2010·Granted Sep 4, 2012·48 cites·3 claims
- 0492US10918700B2Lipid-based nanoparticles and use of same in optimized insulin dosing regimensSDG INC·Filed 2020·Granted Feb 16, 2021·2 cites·26 claims
- 0591US11077173B2Lipid-based nanoparticles and methods using sameSDG INC·Filed 2020·Granted Aug 3, 2021·2 cites·30 claims
- 0691US9034372B2Lipid construct for delivery of insulin to a mammalSDG INC·Filed 2014·Granted May 19, 2015·10 cites·6 claims
- 0791US8846053B2Orally bioavailable lipid-based constructsBLAIR GEHO W·Filed 2010·Granted Sep 30, 2014·8 cites·7 claims
- 0891US7871641B2Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammalSDG INC·Filed 2006·Granted Jan 18, 2011·9 cites·14 claims
- 0990US6063400ATargeted liposomal constructs for diagnostic and therapeutic usesSDG INC·Filed 1998·Granted May 16, 2000·97 cites·36 claims
- 1088US7858116B2Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammalSDG INC·Filed 2006·Granted Dec 28, 2010·10 cites·13 claims
- 1186US10463616B2Lipid construct for delivery of insulin to a mammalSDG INC·Filed 2018·Granted Nov 5, 2019·3 cites·11 claims
- 1286US8962015B2Orally bioavailable lipid-based constructsLAU JOHN R·Filed 2007·Granted Feb 24, 2015·7 cites·2 claims
- 1385US11071715B2Lipid-based nanoparticles and methods using sameSDG INC·Filed 2019·Granted Jul 27, 2021·1 cites·26 claims
- 1484US10568835B2Orally bioavailable lipid-based constructsSDG INC·Filed 2015·Granted Feb 25, 2020·3 cites·16 claims
- 1584US4921644AMucin directed lipsomeTECHNOLOGY UNLIMITED INC·Filed 1988·Granted May 1, 1990·71 cites·4 claims
- 1682US10004686B2Lipid construct for delivery of insulin to a mammalSDG INC·Filed 2013·Granted Jun 26, 2018·3 cites·24 claims
- 1782US7169410B1Targeted liposomal drug delivery systemSDG INC·Filed 1999·Granted Jan 30, 2007·54 cites·24 claims
- 1881US2025288521A1Orally bioavailable lipid-based constructsDIASOME PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1980US9943602B2Orally bioavailable lipid-based constructsSDG INC·Filed 2014·Granted Apr 17, 2018·3 cites·9 claims
- 2080US9145453B2Orally bioavailable lipid-based constructsBLAIR GEHO W·Filed 2010·Granted Sep 29, 2015·5 cites·5 claims
- 2179US4863896ADiabetic control by combined insulin formsTECHNOLOGY UNLIMITED INC·Filed 1988·Granted Sep 5, 1989·54 cites·3 claims
- 2278US10751418B2Orally bioavailable lipid-based constructsSDG INC·Filed 2013·Granted Aug 25, 2020·1 cites·9 claims
- 2378US4722937AAntitoxin vaginal products and catamenialsJACOB JOSEPH·Filed 1986·Granted Feb 2, 1988·53 cites·3 claims
- 2478US2024139288A1Lipid-based nanoparticles and use of same in optimized insulin dosing regimensSDG INC·Filed 2023·Application pending·0 cites
- 2576US2020261363A1Lipid construct for delivery of insulin to a mammalSDG INC·Filed 2019·Application pending·0 cites
- 2675US2023172868A1Lipid-based nanoparticles with enhanced stabilitySDG INC·Filed 2023·Application pending·0 cites
- 2773US2024108585A1Compositions comprising lipid-based nanoparticles for treating diabetes mellitusSDG INC·Filed 2023·Application pending·0 cites
- 2871US11517529B2Orally bioavailable lipid-based constructsSDG INC·Filed 2020·Granted Dec 6, 2022·0 cites·17 claims
- 2971US4602043ATreatment for hypoglycemiaTECHNOLOGY UNLIMITED INC·Filed 1984·Granted Jul 22, 1986·28 cites·3 claims
- 3071US2010080773A1Orally Bioavailable Lipid-Based ConstructsSDG INC·Filed 2009·Application pending·0 cites
- 3168US2021379160A1Lipid-based nanoparticles and use of same in optimized insulin dosing regimensSDG INC·Filed 2021·Application pending·0 cites
- 3265US2021137838A1Lipid-based nanoparticles with enhanced stabilitySDG INC·Filed 2018·Application pending·0 cites
- 3364US2007104777A1Targeted liposomal drug delivery systemLAU JOHN R·Filed 2006·Application pending·0 cites
- 3462US4704394ATreatment for hyperactivityTECHNOLOGY UNLIMITED INC·Filed 1986·Granted Nov 3, 1987·26 cites·5 claims
- 3562US2020375913A1Compositions comprising lipid-based nanoparticles for treating diabetes mellitusSDG INC·Filed 2019·Application pending·0 cites
- 3660US2011135725A1Lipid Construct for Delivery of Insulin to a MammalSDG INC·Filed 2006·Application pending·0 cites
- 3759US5567432AMasking of liposomes from RES recognitionFiled 1995·Granted Oct 22, 1996·21 cites·7 claims
- 3859US4740375AGelcoresTECHNOLOGY UNLIMITED INC·Filed 1985·Granted Apr 26, 1988·22 cites·3 claims
- 3956US8303983B2Targeted liposomal drug delivery systemLAU JOHN R·Filed 2010·Granted Nov 6, 2012·0 cites·6 claims
- 4056US2022110870A1Lipid construct for delivery of insulin to a mammalSDG INC·Filed 2021·Application pending·0 cites
- 4155US4767615ADental therapy by vesicle deliveryTECHNOLOGY UNLIMITED INC·Filed 1986·Granted Aug 30, 1988·19 cites·2 claims
- 4254US4942036ATherapy by vesicle delivery to the hydroxyapatite of boneBLAIR GEHO W·Filed 1988·Granted Jul 17, 1990·18 cites·9 claims
- 4354US2007218117A1Supra molecular construct for delivery of interferon to a mammalSDG INC·Filed 2006·Application pending·0 cites
- 4448US6177099B1Masking of liposomes from RES recognitionSDG INC·Filed 1997·Granted Jan 23, 2001·11 cites·4 claims
- 4547US2002177546A1Dual therapy method of treating and controlling diabetes mellitusFiled 2001·Application pending·0 cites
- 4647US2002137787A1Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitusFiled 2001·Application pending·0 cites
- 4747US2002147134A1Method of preventing and treating the complications of insulin dependent diabetes mellitusFiled 2001·Application pending·0 cites
- 4845US2010129428A1Supra molecular construct for delivery of interferon to a mammalSDG INC·Filed 2006·Application pending·0 cites
- 4942US5436010AHair penetrant and carrierSDG TECHNOLOGY INC·Filed 1993·Granted Jul 25, 1995·11 cites·3 claims
- 5042US2012035105A1Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related AilmentsBLAIR GEHO W·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when W. Blair Geho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →